The tiny dollar amount makes this cluster noise — not a signal. However, the unanimous director buying immediately after a poison pill termination and a distressed-company credit line may reflect confidence from the board. Monitor the company's next 10-Q for cash burn trends and any further equity financing, as the credit line suggests liquidity pressure.
Price Chart
Executive Summary
Three directors of BGDE purchased a combined $36,868 in open-market shares over two days (June 11-12, 2026), following the company's termination of its poison pill and a $40M revolving credit line from Endeavor Blockchain. The total insider buying represents just 0.09% of the $40M market cap, making it trivial in economic terms despite being a unanimous director cluster.
Key Financial Metrics
Key Facts
- Three directors (Danges, Morrison, Hough) purchased a total of 5,021 shares for $36,868 on June 11-12, 2026
- Market cap is approximately $40M; insider buys represent ~0.09% of market cap
- Prior week: BGDE terminated poison pill (8-K June 9) and secured $40M revolving credit line from Endeavor Blockchain at 12% interest (8-K June 3)
- The credit line note acknowledges the company's 'current distressed financial condition'
Financial Impact
Insider purchases of $36,868 are negligible relative to $40M market cap — no material trading impact
Risk Factors
- Company acknowledged distressed financial condition in the credit line promissory note — going-concern risk is elevated
- Previous AI/HPC colocation deal generated zero revenue and is no longer active, highlighting execution challenges
- Total insider buying is immaterial in dollar terms — may not indicate genuine insider conviction
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BGDE-1781299715893 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $3.86 | awaiting T+5 | — | $4.02 (+4.15%) |
Sep 28, 2026 28d ago | SC 13D/A | $5.32 $5.35 | ▲ +0.56% | ▼ −1.38% | $4.02 (−24.44%) |
Sep 24, 2026 4w ago | 8-K | $6.24 $5.28 | ▲ +15.38% | ▲ +14.97% | $4.02 (+35.58%) |
Aug 12, 2026 10w ago | Press Release | $6.06 $7.22 | ▼ −19.14% | ▼ −21.11% | $4.02 (+33.66%) |
Jul 29, 2026 12w ago | Press Release | $5.64 | awaiting T+5 | — | $4.02 (−28.72%) |
Jul 20, 2026 14w ago | S-3 | $5.96 $5.27 | ▲ +11.58% | ▲ +10.35% | $4.02 (+32.55%) |
Jul 20, 2026 14w ago | 8-K | $5.70 $5.39 | ▲ +5.44% | ▲ +5.01% | $4.02 (+29.47%) |
Jul 10, 2026 15w ago | Insider Buy | $6.89 $5.71 | ▼ −17.13% | ▼ −16.34% | $4.02 (−41.65%) |
Jul 6, 2026 16w ago | 8-K | $8.15 $7.43 | ▲ +8.83% | ▲ +9.32% | $4.02 (+50.67%) |
Jul 2, 2026 16w ago | Insider Buy | $7.45 $7.77 | ▲ +4.30% | ▲ +3.36% | $4.02 (−46.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers